29 related articles for article (PubMed ID: 7913884)
21. Chondrosarcoma: biology, genetics, and epigenetics.
Chow WA
F1000Res; 2018; 7():. PubMed ID: 30519452
[TBL] [Abstract][Full Text] [Related]
22. c-erbB-2 oncogene as a prognostic marker in breast cancer.
Perren TJ
Br J Cancer; 1991 Mar; 63(3):328-32. PubMed ID: 1672251
[No Abstract] [Full Text] [Related]
23. Identification and interpretation of epidermal growth factor and c-erbB-2 overexpression.
Gusterson BA
Eur J Cancer; 1992; 28(1):263-7. PubMed ID: 1348953
[TBL] [Abstract][Full Text] [Related]
24. Novel strategies for the treatment of chondrosarcomas: targeting integrins.
Chen JC; Fong YC; Tang CH
Biomed Res Int; 2013; 2013():396839. PubMed ID: 24490159
[TBL] [Abstract][Full Text] [Related]
25. [Overexpression of c-erbB-2 proto-oncogene product in chondrosarcomas].
Li N; Shen LH; Zhu QF
Zhonghua Bing Li Xue Za Zhi; 1994 Feb; 23(1):37-9. PubMed ID: 7913884
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetics as a tool in the histologic subclassification of chondrosarcomas.
Dijkhuizen T; van den Berg E; Molenaar WM; Oosterhuis JW; Dam A; Wiersema J; Schraffordt Koops H; de Jong B
Cancer Genet Cytogenet; 1994 Sep; 76(2):100-5. PubMed ID: 7923056
[TBL] [Abstract][Full Text] [Related]
27. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and prognosis of chondrosarcoma of bone.
Rozeman LB; Hogendoorn PC; Bovée JV
Expert Rev Mol Diagn; 2002 Sep; 2(5):461-72. PubMed ID: 12271817
[TBL] [Abstract][Full Text] [Related]
29. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
Singleton TP; Strickler JG
Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]